Expression of p53 family genes in urinary bladder cancer: correlation with disease aggressiveness and recurrence

By Papadogianni Danae   Soulitzis Nikolaos   Delakas Demetrios   Spandidos Demetrios  

Tumor Biology, Vol. 35, Iss. 3, 2014-03 ,pp. : 2481-2489

Springer Publishing Company

Access to resources Recommend Favorite

p53 in noncancerous bladder mucosa as a marker of disease recurrence in patients with superficial transitional cell carcinoma of the bladder - Possible clinical implications

By Friedrich M.G.   Schwaibold H.   Wintzer O.   Pichlmeier U.   Huland H.  

Urologic Oncology: Seminars and Original Investigations, Vol. 3, Iss. 4, 1997-07 ,pp. : 125-131

Elsevier

Access to resources Recommend Favorite

Pretreatment levels of serum osteoprotegerin and p53 protein and urine telomerase as prognostic factors affecting survival in Egyptian bladder cancer patients

By        

Oncology Letters, Vol. 11, Iss. 1, 2016-01 ,pp. : 823-830

Spandidos Publications

Access to resources Recommend Favorite

Associations of the BRAF (V600E) mutation and p53 protein expression with clinicopathological features of papillary thyroid carcinomas patients

By                

Oncology Letters, Vol. 10, Iss. 3, 2015-01 ,pp. : 1882-1888

Spandidos Publications

Access to resources Recommend Favorite

Cell-free microRNAs in urine as diagnostic and prognostic biomarkers of bladder cancer

By                    

International Journal of Oncology, Vol. 41, Iss. 5, 2012-01 ,pp. : 1871-1878

Spandidos Publications

Access to resources Recommend Favorite